Shares of Aethlon Medical (AEMD) is currently surging nearly 385% after the company announced an all-stock merger with North Immunology. The company also announced an oversubscribed $180 million private placement to advance North's antibody drug candidate NOR-101.
The stock is currently trading at $6.94, up $5.51 or 384.97%, on the Nasdaq. It opened at $8.54 after closing the previous session at $1.43. The stock has traded between $1.41 and $41.50 over the past 52 weeks.
For comments and feedback contact: [email protected]
Business News
September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.